Literature DB >> 25887787

17 years of clinical experience with phosphodiesterase type 5 inhibitors: what do we have yet to learn?

Paolo Verze1, Tommaso Cai2, Alessandro Palmieri3, Vincenzo Mirone3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25887787     DOI： 10.1016/j.eururo.2015.04.007

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.

Authors:  Camilla R Madeira; Fernanda S Tonin; Mariana M Fachi; Helena H Borba; Vinicius L Ferreira; Leticia P Leonart; Aline F Bonetti; Rogerio P Moritz; Angela C L B Trindade; Alan G Gonçalves; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  World J Urol       Date:  2020-05-09       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.